Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding
The Pharma Data
AUGUST 20, 2020
On Thursday, domestic and global companies bid for contracts on 56 medicines. . DEVELOP A UNIFIED SCIENTIFIC VOICE. Companies such as AstraZeneca, Sanofi and Eli Lilly have managed to keep business under the aggressive procurement program, but they had to live with major discounts. . Virtual Event.
52 
Let's personalize your content